Madrigal Pharmaceuticals announced its preliminary Q4 and full-year results. The company topped the official Wall Street estimates, but seems to have missed the so-called "whisper numbers ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

NEW YORK -- The Mets struck a deal for another potential bench bat on Friday, signing infielder Nick Madrigal to a one-year pact. It's a split contract worth different amounts in the Majors and Minors ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full ...

The Mets have a one-year agreement with infielder Nick Madrigal, the club announced. It’s reportedly a split deal that pays the Wasserman client $1.35MM in the majors, with another $500K ...

Copyright 2025 The Associated Press. All Rights Reserved. Chicago Cubs third baseman Nick Madrigal throws to first base to get San Francisco Giants’ Patrick Bailey ...

Looking to add to their infield depth, the New York Mets agreed to a one-year deal with veteran Nick Madrigal on Friday, league sources confirmed. The New York Post first reported the agreement.

Madrigal said that all patients enrolled in MAESTRO-NASH - which include up to 2,000 in total - are continuing on therapy after the initial 52-week treatment period.

Could this spell the end of Candelita in Queens? OMG. The New York Mets have signed versatile infielder Nick Madrigal to a split one-year contract worth differing amounts in the majors and minors ...

Investor expectations may be too high, however. Madrigal unveiled those figures Monday morning. The company said that its preliminary results indicated it earned $100 million to $103 million in ...